Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PMV Pharmaceuticals (PMVP)
NASDAQ:PMVP
PMV Pharmaceuticals (PMVP) Stock Price & Analysis
72 Followers
PMVP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.18 - $9.72
Previous Close$1.7
Volume643.44K
Average Volume (3M)556.16K
Market Cap
$87.45M
Enterprise Value-$102.32M
Total Cash (Recent Filing)$203.06M
Total Debt (Recent Filing)$13.29M
Price to Earnings (P/E)-1.2
Beta1.80
Next Earnings
May 09, 2024EPS Estimate
-$0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.44
Shares Outstanding51,443,488
10 Day Avg. Volume627,293
30 Day Avg. Volume556,161
Standard Deviation0.26
R-Squared0.11
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda5.01
Forecast
1Y Price Target
$5.00Price Target Upside194.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
PMV Pharmaceuticals News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PMVP FAQ
What was PMV Pharmaceuticals’s price range in the past 12 months?
PMV Pharmaceuticals lowest stock price was $1.18 and its highest was $9.72 in the past 12 months.
What is PMV Pharmaceuticals’s market cap?
Currently, no data Available
When is PMV Pharmaceuticals’s upcoming earnings report date?
PMV Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 14 days.
How were PMV Pharmaceuticals’s earnings last quarter?
PMV Pharmaceuticals released its earnings results on Feb 29, 2024. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.37 by $0.07.
Is PMV Pharmaceuticals overvalued?
According to Wall Street analysts PMV Pharmaceuticals’s price is currently Undervalued.
Does PMV Pharmaceuticals pay dividends?
PMV Pharmaceuticals does not currently pay dividends.
What is PMV Pharmaceuticals’s EPS estimate?
PMV Pharmaceuticals’s EPS estimate is -$0.37.
How many shares outstanding does PMV Pharmaceuticals have?
PMV Pharmaceuticals has 51,443,490 shares outstanding.
What happened to PMV Pharmaceuticals’s price movement after its last earnings report?
PMV Pharmaceuticals reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.37. Following the earnings report the stock price went up 1.622%.
Which hedge fund is a major shareholder of PMV Pharmaceuticals?
Among the largest hedge funds holding PMV Pharmaceuticals’s share is Woodline Partners LP. It holds PMV Pharmaceuticals’s shares valued at 6M.
---
PMV Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (194.12% Upside)
$5.00 (194.12% Upside)
Blogger Sentiment
Neutral
PMVP Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 723.7K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.02%
12-Months-Change
Fundamentals
Return on Equity
-29.24%
Trailing 12-Months
Asset Growth
-6.72%
Trailing 12-Months
Company Description
PMV Pharmaceuticals
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
---
PMVP Stock 12 Months Forecast
Average Price Target
$5.00
▲(194.12% Upside)
Technical Analysis
Best Analysts Covering PMVP
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-49.98%
reiterated a buy rating 2 months ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -49.98% per trade.
---